USA - NYSE:TMO - US8835561023 - Common Stock
Overall TMO gets a fundamental rating of 5 out of 10. We evaluated TMO against 57 industry peers in the Life Sciences Tools & Services industry. While TMO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. TMO has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.5% | ||
ROE | 13.04% | ||
ROIC | 7.01% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 18.18% | ||
PM (TTM) | 15.24% | ||
GM | 41.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.71 | ||
Altman-Z | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.93 | ||
Quick Ratio | 1.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.42 | ||
Fwd PE | 22.61 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 34.05 | ||
EV/EBITDA | 21.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.32% |
NYSE:TMO (10/21/2025, 9:41:08 AM)
556.41
+12.57 (+2.31%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.32% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.42 | ||
Fwd PE | 22.61 | ||
P/S | 4.86 | ||
P/FCF | 34.05 | ||
P/OCF | 27.73 | ||
P/B | 4.16 | ||
P/tB | N/A | ||
EV/EBITDA | 21.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.5% | ||
ROE | 13.04% | ||
ROCE | 8.88% | ||
ROIC | 7.01% | ||
ROICexc | 7.56% | ||
ROICexgc | 31.47% | ||
OM | 18.18% | ||
PM (TTM) | 15.24% | ||
GM | 41.34% | ||
FCFM | 14.28% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.71 | ||
Debt/EBITDA | 3.08 | ||
Cap/Depr | 49.03% | ||
Cap/Sales | 3.26% | ||
Interest Coverage | 250 | ||
Cash Conversion | 70.63% | ||
Profit Quality | 93.71% | ||
Current Ratio | 1.93 | ||
Quick Ratio | 1.5 | ||
Altman-Z | N/A |